ProQR Therapeutics (PRQR) Minority Interest (2017 - 2023)
ProQR Therapeutics (PRQR) posted Minority Interest of -$315788.1 for Q2 2023, up 3.85% sequentially from -$328442.6 in Q1 2023, and up 25.08% YoY from -$252473.5 in Q2 2022.
ProQR Therapeutics (PRQR) Minority Interest (2017 - 2023) Analysis & Trends
ProQR Therapeutics has reported Minority Interest for 7 years, with the latest figure at -$315788.1 in Q2 2023.
- Quarterly Minority Interest rose 25.08% year-over-year to -$315788.1 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was -$315788.1 (up 25.08% YoY) and the FY2022 annual result came in at -$391775.0, up 45.19% from the prior year.
- Minority Interest grew to -$315788.1 in Q2 2023 per PRQR's latest filing, from -$328442.6 in the prior quarter.
- Over five years, Minority Interest peaked at -$360.31 in Q1 2019 and troughed at -$690958.5 in Q4 2021.
- A 5-year average of -$473031.1 and a median of -$525985.1 in 2019 frame the typical range for Minority Interest.
- The sharpest annual moves came in 2019 and 2021: Minority Interest plunged 249850.6% in 2019, then surged 99.88% in 2021.
- Over 5 years, Minority Interest stood at -$549016.3 in 2019, then dropped by 18.36% to -$649798.0 in 2020, then decreased by 6.33% to -$690958.5 in 2021, then surged by 43.3% to -$391775.0 in 2022, then grew by 19.4% to -$315788.1 in 2023.
- According to Business Quant data, Minority Interest over the past three periods registered -$315788.1, -$328442.6, and -$391775.0 for Q2 2023, Q1 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | ProQR Therapeutics | 206.80 Mn | 111.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -315,788.07 |
| Mar 31, 2023 | -328,442.60 |
| Dec 31, 2022 | -391,774.99 |
| Sep 30, 2022 | -384,152.52 |
| Jun 30, 2022 | -421,487.39 |
| Mar 31, 2022 | -686,870.68 |
| Dec 31, 2021 | -690,958.45 |
| Sep 30, 2021 | -689,883.08 |
| Jun 30, 2021 | -678,004.82 |
| Mar 31, 2021 | -670.67 |
| Dec 31, 2020 | -649,797.97 |
| Sep 30, 2020 | -623,753.24 |
| Jun 30, 2020 | -579,368.03 |
| Mar 31, 2020 | -572,944.35 |
| Dec 31, 2019 | -549,016.29 |
| Sep 30, 2019 | -502,953.97 |
| Jun 30, 2019 | -448,332.00 |
| Mar 31, 2019 | -360.31 |
| Dec 31, 2018 | -262.52 |
| Sep 30, 2018 | -201.22 |